Literature DB >> 29486587

Do clinicians prescribe exercise similarly in patients with different cardiovascular diseases? Findings from the EAPC EXPERT working group survey.

Dominique Hansen1,2, Gustavo Rovelo Ruiz3, Patrick Doherty4, Marie-Christine Iliou5, Tom Vromen6, Sally Hinton7, Ines Frederix1,2,8, Matthias Wilhelm9, Jean-Paul Schmid10, Ana Abreu11, Marco Ambrosetti12, Esteban Garcia-Porrero13, Karin Coninx3, Paul Dendale1,2.   

Abstract

Background Although disease-specific exercise guidelines for cardiovascular disease (CVD) are widely available, it remains uncertain whether these different exercise guidelines are integrated properly for patients with different CVDs. The aim of this study was to assess the inter-clinician variance in exercise prescription for patients with various CVDs and to compare these prescriptions with recommendations from the EXercise Prescription in Everyday practice and Rehabilitative Training (EXPERT) tool, a digital decision support system for integrated state-of-the-art exercise prescription in CVD. Design The study was a prospective observational survey. Methods Fifty-three CV rehabilitation clinicians from nine European countries were asked to prescribe exercise intensity (based on percentage of peak heart rate (HRpeak)), frequency, session duration, programme duration and exercise type (endurance or strength training) for the same five patients. Exercise prescriptions were compared between clinicians, and relationships with clinician characteristics were studied. In addition, these exercise prescriptions were compared with recommendations from the EXPERT tool. Results A large inter-clinician variance was found for prescribed exercise intensity (median (interquartile range (IQR)): 83 (13) % of HRpeak), frequency (median (IQR): 4 (2) days/week), session duration (median (IQR): 45 (18) min/session), programme duration (median (IQR): 12 (18) weeks), total exercise volume (median (IQR): 1215 (1961) peak-effort training hours) and prescription of strength training exercises (prescribed in 78% of all cases). Moreover, clinicians' exercise prescriptions were significantly different from those of the EXPERT tool ( p < 0.001). Conclusions This study reveals significant inter-clinician variance in exercise prescription for patients with different CVDs and disagreement with an integrated state-of-the-art system for exercise prescription, justifying the need for standardization efforts regarding integrated exercise prescription in CV rehabilitation.

Entities:  

Keywords:  Cardiovascular disease; EXPERT tool; exercise prescription

Mesh:

Year:  2018        PMID: 29486587     DOI: 10.1177/2047487318760888

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  9 in total

Review 1.  Critical Reappraisal of the Role and Importance of Exercise Intervention in the Treatment of Obesity in Adults.

Authors:  Kenneth Verboven; Dominique Hansen
Journal:  Sports Med       Date:  2021-03       Impact factor: 11.136

Review 2.  Exercise Prescription in Patients with Different Combinations of Cardiovascular Disease Risk Factors: A Consensus Statement from the EXPERT Working Group.

Authors:  Dominique Hansen; Josef Niebauer; Veronique Cornelissen; Olga Barna; Daniel Neunhäuserer; Christoph Stettler; Cajsa Tonoli; Eugenio Greco; Robert Fagard; Karin Coninx; Luc Vanhees; Massimo F Piepoli; Roberto Pedretti; Gustavo Rovelo Ruiz; Ugo Corrà; Jean-Paul Schmid; Constantinos H Davos; Frank Edelmann; Ana Abreu; Bernhard Rauch; Marco Ambrosetti; Simona Sarzi Braga; Paul Beckers; Maurizio Bussotti; Pompilio Faggiano; Esteban Garcia-Porrero; Evangelia Kouidi; Michel Lamotte; Rona Reibis; Martijn A Spruit; Tim Takken; Carlo Vigorito; Heinz Völler; Patrick Doherty; Paul Dendale
Journal:  Sports Med       Date:  2018-08       Impact factor: 11.136

3.  Intelligent Personalized Exercise Prescription Based on an eHealth Promotion System to Improve Health Outcomes of Middle-Aged and Older Adult Community Dwellers: Pretest-Posttest Study.

Authors:  Ting Sun; Yang Xu; Hui Xie; Zuchang Ma; Yu Wang
Journal:  J Med Internet Res       Date:  2021-05-24       Impact factor: 7.076

4.  Increased Physical Activity Post-Myocardial Infarction Is Related to Reduced Mortality: Results From the SWEDEHEART Registry.

Authors:  Orjan Ekblom; Amanda Ek; Åsa Cider; Kristina Hambraeus; Mats Börjesson
Journal:  J Am Heart Assoc       Date:  2018-12-18       Impact factor: 5.501

5.  Self-care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology.

Authors:  Tiny Jaarsma; Loreena Hill; Antoni Bayes-Genis; Hans-Peter Brunner La Rocca; Teresa Castiello; Jelena Čelutkienė; Elena Marques-Sule; Carla M Plymen; Susan E Piper; Barbara Riegel; Frans H Rutten; Tuvia Ben Gal; Johann Bauersachs; Andrew J S Coats; Ovidiu Chioncel; Yuri Lopatin; Lars H Lund; Mitja Lainscak; Brenda Moura; Wilfried Mullens; Massimo F Piepoli; Giuseppe Rosano; Petar Seferovic; Anna Strömberg
Journal:  Eur J Heart Fail       Date:  2020-10-20       Impact factor: 15.534

6.  Development of a Novel Clinical Decision Support System for Exercise Prescription Among Patients With Multiple Cardiovascular Disease Risk Factors.

Authors:  Linda S Pescatello; Yin Wu; Gregory A Panza; Amanda Zaleski; Margaux Guidry
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-10-22

Review 7.  Current role and future perspectives of cardiac rehabilitation in coronary heart disease.

Authors:  Eduardo M Vilela; Ricardo Ladeiras-Lopes; Ana Joao; Joana Braga; Susana Torres; Sofia Viamonte; José Ribeiro; Madalena Teixeira; José P Nunes; Ricardo Fontes-Carvalho
Journal:  World J Cardiol       Date:  2021-12-26

8.  Exercise training for cardiovascular patients: Push me across the threshold!

Authors:  Marco Ambrosetti; Dominique Hansen
Journal:  Int J Cardiol Cardiovasc Risk Prev       Date:  2022-05-18

9.  Patterning in Patient Referral to and Uptake of a National Exercise Referral Scheme (NERS) in Wales From 2008 to 2017: A Data Linkage Study.

Authors:  Kelly Morgan; Muhammad Rahman; Graham Moore
Journal:  Int J Environ Res Public Health       Date:  2020-06-02       Impact factor: 4.614

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.